Aberrant methylation of p14ARF, p15INK4b and p16 INK4a genes and location of the primary site in pulmonary squamous cell carcinoma

Pathology International

Volumn 54, Issue 8, 2004, Pages 549-555

  Furonaka, Osamu ^a   Takeshima, Yukio ^a   Awaya, Hirokazu ^a   Ishida, Hajime ^a   Kohno, Nobuoki ^a   Inai, Kouki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Aberrant methylation; p14ARF; p15INK4b; p16 INK4a; Pulmonary squamous cell carcinoma

Indexed keywords

PROTEIN P14; PROTEIN P15; PROTEIN P16;

AGED; ARTICLE; CANCER LOCALIZATION; CHROMOSOME 9P; EPIGENETICS; GENE CLUSTER; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CARCINOMA; METHYLATION; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; DNA-DIRECTED DNA POLYMERASE; GENE SILENCING; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEINS;

EID: 4344672497     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2004.01663.x     Document Type: Article

References (33)

1. Gardar AF, Minna JD. Molecular detection of early lung cancer. J Natl Cancer Inst 1999; 91: 299-301.
2. Zöchbauer-Müller S, Gazdar AF, Minna JD. Molecular pathogenesis of lung cancer. Annu Rev Physiol 2002; 60: 681-708.
3. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell cycle control causing specific inhibition of cyclinD/CDK4. Nature 1993; 336: 704-7.
4. Sanchez-Cespedes M, Reed AL, Buta M et al. Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer. Oncogene 1999; 18: 5843-9.
5. Sherr CJ. G1 phase progression: cycling on cue. Cell 1994; 79: 551-5.
6. Kamb A, Guis NA, Weaver-Feldhaus J et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264: 436-40.
7. Taga S, Osaki T, Ohgami A et al. Prognostic value of immunohistochemical detection of p16INK4 expression in non small cell lung carcinoma. Cancer 1997; 80: 389-95.
8. Kashiwabara K, Oyama T, Sano T, Fukuda T, Nakajima T. Correlation between methylation status of the p16/CDKN2 gene and the expression of p16 and Rb proteins in primary non-small cell lung cancers. Int J Cancer 1998; 79: 215-20.
9. Tanaka H, Fujii Y, Hirabayashi H et al. Disruption of the RB pathway and cell-proliferative activity in non-small-cell lung cancers. Int J Cancer 1998; 79: 111-15.
10. Akin H, Yilmazbayhan D, Kilicaslan Z et al. Clinical significance of p16INK4A and retinoblastoma proteins in non-small lung carcinoma. Lung Cancer 2002; 38: 253-60.
11. Huang CI, Taki T, Higashiyama M, Kohno N, Miyake M. p16 protein expression is associated with poor prognosis in squamous cell carcinoma of the lung. Br J Cancer 2000; 82: 374-80.
12. Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetic joins genetics. Trends Genet 2000; 16: 168-74.
13. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001; 61: 3225-9.
14. Kim DH, Nelson HH, Wiencke JK et al. p16 (INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res 2001; 61: 3419-24.
15. Ogi K, Toyota M, Toyota MO et al. Aberrant methylation of multiple genes and clinicopathological features in oral squamous cell carcinoma. Clin Cancer Res 2002; 8: 3164-71.
16. Colby TV, Koss MN, Travis WD. Tumors of the lower respiratory tract. In: Rosai J, ed. Atlas of Tumor Pathology. 3rd Series, Fascicle 13. Washington DC: Armed Forces Institute of Pathology, 1995; 145-78.
17. Tomashefski JF Jr, Connors AF Jr, Rosenthal ES, Hsiue IL. Peripheral vs central squamous cell carcinoma of the lung. Arch Pathol Lab Med 1990; 114: 468-74.
18. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E. Histological typing of lung and pleural tumours. In: Travis WD, ed. World Health Organization Pathology. International Histological Classification of Tumours, 3rd edn. Berlin: Springer-Verlag, 1999.
19. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111: 1710-17.
20. Zöchbauer-Müller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res 2001; 61: 249-55.
21. Herman JG, Jen J, Merlo A, Baylin SB. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B1. Cancer Res 1996; 56: 722-7.
22. INK4a gene inactivation by hypermethylation in lung cancer during the process of metastasis and its relation to the status of p53. Clin Cancer Res 2000; 6: 4307-13.
23. Jarmalaite S, Kannio A, Anttila S, Lazutka JR, Husgafvel-Pursiainen K. Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer. Int J Cancer 2003; 106: 913-18.
24. Yanagawa N, Tamura G, Oizumi H, Takahashi N, Shimazaki Y, Motoyama T. Promoter hypermethylation of tumor suppressor and tumor-related genes in non-small cell lung cancers. Cancer Sci 2003; 94: 589-92.
25. Belinsky SA, Nikula KJ, Palmisano WA et al. Aberrant methylation of p16 (INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci USA 1998; 95: 11 891-6.
26. Palmisano WA, Divine KK, Saccomanno G et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 2000; 60: 5954-8.
27. Kersting M, Friedl C, Kraus A, Behn M, Pankow W, Schuermann M. Differential frequencies of p16 (INK4a) promoter hypermethylation, p53 mutation and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smokers. J Clin Oncol 2000; 18: 3221-9.
28. Kurakawa E, Shimamoto T, Utsumi K, Hirano T, Kato H, Ohyashiki K. Hypermethylation of p16 (INK4a) and p15 (INK4b) genes in non-small cell lung cancer. Int J Oncol 2001; 19: 277-81.
29. Shintani S, Nakahara Y, Mihara M, Ueyama Y, Matsumura T. Inactivation of p14ARF, p15INK4B and p16INK4A gene is a frequent event in human oral squamous cell carcinoma. Oral Oncol 2001; 37: 498-504.
30. Viswanathan M, Tsuchida N, Shanmugam G. Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma. Int J Cancer 2003; 105: 41-6.
31. Zöchbauer-Müller S, Lam S, Toyooka S et al. Aberrant methylation of multiple genes in the upper aero digestive tract epithelium of heavy smokers. Int J Cancer 2003; 107: 612-16.
32. Kinoshita I, Dosaka H, Mishima T et al. Altered p16INK4a and retinoblastoma protein status in non-small-cell lung cancer; potential synergistic effect with altered p53 protein on proliferative activity. Cancer Res 1996; 56: 5557-62.
33. Volm M, Koomagi R, Mattern J. Prognostic value of p16INK4A expression in lung adenocarcinoma. Anticancer Res 1998; 18: 2309-12.